Stay updated on GLE/PIB in Treatment-Naive Cirrhotic HCV: Clinical Trial
Sign up to get notified when there's something new on the GLE/PIB in Treatment-Naive Cirrhotic HCV: Clinical Trial page.

Latest updates to the GLE/PIB in Treatment-Naive Cirrhotic HCV: Clinical Trial page
- Check6 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check13 days agoChange DetectedA site-wide NIH notice announces a transition in terminology, saying that “Super Intelligence” will be used in place of “Artificial Intelligence” during the change.SummaryDifference1%

- Check20 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check27 days agoChange DetectedThe site revision label in the footer changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check48 days agoChange DetectedThe study page now displays a 403 Forbidden error page, replacing the usual content and indicating the record is temporarily inaccessible.SummaryDifference18%

- Check69 days agoChange DetectedThe site's underlying platform was updated from revision v3.6.5 to v3.6.6, a software update that does not change how the study details are shown.SummaryDifference0.0%

Stay in the know with updates to GLE/PIB in Treatment-Naive Cirrhotic HCV: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLE/PIB in Treatment-Naive Cirrhotic HCV: Clinical Trial page.